We are live on
!
Find out more
Alkeon Capital Management Portfolio holdings
AUM
$59.5B
1-Year Est. Return
51.63%
This Fund
S&P 500
This Quarter
Est. Return
+12.3%
1 Year Est. Return
+51.63%
3 Year Est. Return
+162.63%
5 Year Est. Return
+168.42%
10 Year Est. Return
+1,374.92%
AUM
$57.2B
AUM Growth
+$11.8B
(+26%)
Cap. Flow
+$5.57B
Cap. Flow
% of AUM
9.75%
Top 10 Holdings %
Top 10 Hldgs %
71.23%
Holding
131
New
5
Increased
39
Reduced
56
Closed
15
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$426M |
| 2 |
Microsoft
MSFT
|
+$193M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$143M |
| 4 |
New Oriental
EDU
|
+$121M |
| 5 |
Amazon
AMZN
|
+$98.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$189M |
| 2 |
Pinduoduo
PDD
|
+$112M |
| 3 |
TSMC
TSM
|
+$77M |
| 4 |
Synopsys
SNPS
|
+$70.1M |
| 5 |
Lam Research
LRCX
|
+$70M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.06% |
| 2 | Communication Services | 6.08% |
| 3 | Consumer Discretionary | 5.43% |
| 4 | Financials | 2.55% |
| 5 | Healthcare | 1.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Dynatrace
DT
$14.2B
| $66.4M | 0.12% |
1,290,626
-74,961
| -5% | -$3.51M |
|
77
XP
XP
$8.39B
| $61.4M | 0.11% |
2,617,617
-373,922
| -12% | -$6.34M |
|
|
BPMC
78
DELISTED
Blueprint Medicines
BPMC
| $59.7M | 0.1% |
943,928
+591,745
| +168% | +$32.2M |
|
79
Paylocity
PCTY
$7.98B
| $58.9M | 0.1% |
319,024
-40,438
| -11% | -$7.4M |
|
80
Sarepta Therapeutics
SRPT
$1.77B
| $58.3M | 0.1% |
508,845
-203,989
| -29% | -$26.3M |
|
81
Global Payments
GPN
$22.8B
| $48.8M | 0.09% |
495,772
-176,066
| -26% | -$18.1M |
|
82
KKR & Co
KKR
$92.3B
| $45.8M | 0.08% |
818,076
-116,873
| -13% | -$6.12M |
|
83
CALL
RingCentral
RNG
$5.28B
| $38.5M | 0.07% |
1,175,000
| – | – |
|
84
TG Therapeutics
TGTX
$7.62B
| $38.4M | 0.07% |
1,547,875
-1,142,048
| -42% | -$29.5M |
|
85
dLocal
DLO
$4.24B
| $36.9M | 0.06% |
3,020,287
+1,138,699
| +61% | +$15M |
|
|
GTM
86
ZoomInfo Technologies
GTM
$1.22B
| $36.8M | 0.06% |
1,450,662
+150,266
| +12% | +$3.56M |
|
87
Sea Limited
SE
$69.5B
| $32.7M | 0.06% |
563,168
-603,743
| -52% | -$43.1M |
|
88
Cintas
CTAS
$81.3B
| $29.5M | 0.05% |
237,196
-33,884
| -12% | -$3.98M |
|
89
Rhythm Pharmaceuticals
RYTM
$7.96B
| $28.4M | 0.05% |
1,725,167
-290,799
| -14% | -$5.25M |
|
|
XYZ
90
Block Inc
XYZ
$47.5B
| $26.6M | 0.05% |
+400,000
| New | +$25M |
|
91
CALL
MGM Resorts International
MGM
$11.2B
| $24.6M | 0.04% |
560,000
+60,000
| +12% | +$2.56M |
|
92
Xometry
XMTR
$5.34B
| $23.3M | 0.04% |
1,101,989
+90,701
| +9% | +$1.59M |
|
93
Oric Pharmaceuticals
ORIC
$1.4B
| $23.1M | 0.04% |
2,979,289
+580,037
| +24% | +$3.29M |
|
|
CERE
94
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $22.2M | 0.04% |
699,695
-36,826
| -5% | -$1.13M |
|
95
TransUnion
TRU
$15.3B
| $21.1M | 0.04% |
269,915
-101,702
| -27% | -$7.04M |
|
96
JFrog
FROG
$10.8B
| $16.9M | 0.03% |
608,885
-90,581
| -13% | -$2.07M |
|
97
Stem
STEM
$52.7M
| $16.5M | 0.03% |
144,431
+45,237
| +46% | +$4.49M |
|
|
KLRS
98
Kalaris Therapeutics
KLRS
$96.8M
| $15.7M | 0.03% |
200,222
| – | – |
|
|
ETNB
99
DELISTED
89bio
ETNB
| $13.3M | 0.02% |
700,000
+200,000
| +40% | +$3.51M |
|
100
Marqeta
MQ
$1.66B
| $12.9M | 0.02% |
663,776
-94,746
| -12% | -$1.72M |
|
Similar funds
QCM
NAMI
Alkeon Capital Management's Q2 2023 Portfolio in Review
As of Q2 2023, Alkeon Capital Management held 131 positions worth $57.2B, up 26% from $45.4B the previous quarter. Its ten largest holdings account for 71% of the portfolio.
Alkeon Capital Management deployed $5.57B of net new capital in Q2 2023, opening 5 new positions and adding to 39 existing holdings. Its largest new stake was Invesco QQQ Trust: 425,000 shares worth $157M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 14% a quarter earlier, followed by Communication Services and Consumer Discretionary.
On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $189M trimmed.
- Alkeon Capital Management's largest Q2 2023 buy was Invesco QQQ Trust: 425,000 shares worth $157M.
- Alkeon Capital Management added most to Alphabet (Google) Class A in Q2 2023, an estimated $426M increase.
- Alkeon Capital Management's biggest Q2 2023 reduction was Meta Platforms (Facebook), cutting an estimated $189M.
- Alkeon Capital Management fully exited Peloton Interactive in Q2 2023, selling an estimated $40M.
- Alkeon Capital Management's ten largest holdings make up 71% of its $57.2B portfolio in Q2 2023.
- Alkeon Capital Management opened 5 new positions and closed 15 in Q2 2023.
- Alkeon Capital Management's portfolio value rose 26% quarter-over-quarter to $57.2B.
Based on Alkeon Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.